Long-Term Safety and Efficacy of Dolutegravir in Treatment-Experienced Adolescents With Human Immunodeficiency Virus Infection: Results of the IMPAACT P1093 Study

机译：多洛格韦的长期安全性和有效性在接受过治疗的青少年中有人类免疫缺陷病毒感染：IMPACT P1093研究的结果

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

期刊名称 Journal of the Pediatric Infectious Diseases Society
作者
Rolando M Viani; Theodore Ruel; Carmelita Alvero; Terry Fenton; Edward P Acosta; Rohan Hazra; Ellen Townley; Paul Palumbo; Ann M Buchanan; Cindy Vavro; Rajendra Singh; Bobbie Graham; Patricia Anthony; Kathleen George; Andrew Wiznia; The P1093 Study Team;
展开▼
作者单位

展开▼
年(卷),期 -1(9),2
年度 -1
页码 -1
总页数 7
原文格式 PDF
正文语种
中图分类儿科学;
关键词
Antiretroviral agents; Dolutegravir; HIV-1 integrase inhibitors; Adolescent; long-term follow-up;

机译：抗逆转录病毒药物;Dolutegravir;HIV-1整合酶抑制剂;青少年;长期随访;

相似文献

外文文献
中文文献
专利

1. Safety, Pharmacokinetics and Efficacy of Dolutegravir in Treatment-experienced HIV-1 Infected Adolescents Forty-eight-week Results from IMPAACT P1093 [J] . Viani Rolando M., Alvero Carmelita, Fenton Terry, The Pediatric infectious disease journal . 2015,第11期

机译：Dolutegravir在经治疗经历的HIV-1感染青少年中的安全性，药代动力学和功效来自IMPAACT P1093的48周结果
2. Safety and efficacy of enfuvirtide in combination with darunavir-ritonavir and an optimized background regimen in treatment-experienced human immunodeficiency virus-infected patients: the below the level of quantification study. [J] . DeJesus E, Gottlieb MS, Gathe-JC Jr, Antimicrobial agents and chemotherapy. . 2008,第12期

机译：恩夫韦肽联合达那那韦-利托那韦和优化的背景方案在治疗经验丰富的人类免疫缺陷病毒感染患者中的安全性和有效性：低于定量研究的水平。
3. Safety and efficacy of dolutegravir in treatment-experienced subjects with raltegravir-resistant HIV type 1 infection: 24-week results of the VIKING Study. [J] . Joseph J Eron, Bonaventura Clotet, Jacques Durant, The Journal of Infectious Diseases . 2013,第5期

机译：多洛格韦的安全性和有效性在接受过拉格韦病毒耐药的1型HIV感染治疗的受试者中：VIKING研究的24周结果。
4. Nutrition and Infection: Human Immunodeficiency Virus Infection, Tuberculosis, and Melioidosis [C] . George E. Griffin, Derek Macallan Nestle? Nutrition Workshop . 2001

机译：营养和感染：人类免疫缺陷病毒感染，结核病和纺织品
5. Examining the interaction between human immunodeficiency virus and malaria infections using data from prospective cohort studies in Uganda. [D] . Malamba, Samuel Sewava. 2007

机译：使用来自乌干达的前瞻性队列研究的数据来检查人类免疫缺陷病毒和疟疾感染之间的相互作用。
6. Safety Pharmacokinetics and Efficacy of Dolutegravir in Treatment-Experienced HIV-1 Infected Adolescents: 48-Week Results from IMPAACT P1093 [O] . Rolando M. Viani, Carmelita Alvero, Terry Fenton, -1

机译：在接受治疗的HIV-1感染青少年中多洛格韦的安全性药代动力学和功效：IMPAACT P1093的48周结果
7. Primary Efficacy Endpoint and Safety Results of Ibalizumab in a Phase 3 Study of Heavily Treatment-Experienced Patients With Multidrug-Resistant Human Immunodeficiency Virus-1 Infection [O] . Jacob Lalezari, W. Jeffery Fessel, Shannon Schrader, 2016

机译：Ibalizumab中初级疗效终点和安全结果在3阶段抗性抗性人免疫缺陷病毒-1感染的患者的3阶段研究
8. Economic Consequences of HIV (Human Immunodeficiency Virus) Infection for the Medicaid and Medicare Programs: An Exploratory Study. A Report on a Literature Search and a Review of Selected Research on Human Immunodeficiency Virus (HIV) and Health Care Financing Issues Including Topical Bibliographies and a Consolidated Bibliography [R] . Rayhawk, M. , Baily, M. A. 1989

机译：HIV（人类免疫缺陷病毒）感染医疗补助和医疗保险计划的经济后果：一项探索性研究。文献检索报告及人体免疫机能丧失病毒（HIV）和医疗保健融资问题选择研究的回顾，包括主题书目和综合参考书目

Long-Term Safety and Efficacy of Dolutegravir in Treatment-Experienced Adolescents With Human Immunodeficiency Virus Infection: Results of the IMPAACT P1093 Study

著录项

相似文献

相关主题

期刊订阅